——参考文献——
［1］陈昆田.近距离放射治疗临床应用［M］广州.华南理工大学出版社.2000.8.
［2］孙建衡.妇科恶性肿瘤的近距离放射治疗［M］北京：中国协和医科大学出版社，2005.
［3］成慧君，肖艳，于晓，等.子宫颈癌组织间插植近距离放疗的问题和挑战［J］.中华妇产科杂志，2018，53（9）：644-647.
［4］黄云超.临床肿瘤放射治疗学［M］.昆明：云南科技出版社，2019：86-94.
［5］郭念，姜永梅，李国权.子宫颈癌图像引导的自适应近距离放疗的研究进展［J］.中华妇产科杂志，2014，49（09）：713-716.
［6］程光惠，施丹.ⅠCRU89号报告解析之临床篇——宫颈癌自适应近距离放疗靶区勾画［J］.中华放射肿瘤学杂志，2019，28（4）：250-257.
［7］何明远，汤玉环，赵红福，等.ⅠCRU 89号报告解读（宫颈癌近距离治疗处方、记录和报告）［J］.中华放射肿瘤学杂志，2019，28（2）：140-145.
［8］朱永刚，赵红福，程光惠，等.局部晚期宫颈癌三维适形近距离放疗CT与MRⅠ定位的对比研究［J］.中华放射肿瘤学杂志，2015，24（4）：408-413.
［9］赵欣宇，赵晶，顾菲，等.宫颈癌三维腔内放疗同步体外施源器引导下ⅠMRT剂量学研究［J］.中华放射肿瘤学杂志，2017，26（12）：1421-1425.
［10］安菊生，黄曼妮，吴令英，等.Ⅱb～Ⅲb期子宫颈残端癌放疗方式的探讨［J］.中华妇产科杂志，2013，48（09）：654-659.
［11］林霞，王铁君，王嘉鹏，等，ⅠPSA联合宫颈中心加量在局部晚期宫颈癌腔内联合组织间插植治疗中的应用［J］.中华放射肿瘤学杂志，2021，30（30）.
［12］冯宁远，殷蔚伯.国内近距离放疗发展的特点和临床剂量学存在的误区［J］.中华放射肿瘤学杂志，1995，04（3）：200-202.
［13］赵祥丽，殷锟鹏，赵晶，等.子宫颈残端癌调强放疗或常规放疗联合腔内近距离放疗效果比较［J］.肿瘤研究与临床，2019，31（1）：6-10.
［14］张宝玉，王铁君.外阴癌放射治疗进展［J］.国际肿瘤学杂志，2019，46（11）：699-704.
［15］张宁，程光惠.宫颈癌腔内联合组织间插植近距离放疗应用进展［J］.中华放射肿瘤学杂志，2016，25（8）：895-901.
［16］叶伟军，曹新平，欧阳翼.局部晚期宫颈癌三维CT引导下加速超分割后装治疗的临床观察［J］.中华肿瘤防治杂志，2014，21（8）：626-629.
［17］张宁，赵志鹏，程光惠，等.局部晚期宫颈癌腔内联合组织间插植3D-ⅠGBT的剂量学研究［J］.中华放射肿瘤学杂志 2015，24（3）：267-270.
［18］江萍，张福泉，程光惠，等.复发宫颈癌近距离治疗专家共识［J］.中华放射肿瘤学杂志，2020，29（09）：721-729.
［19］Assenholt MS，Petersen JB，Nielsen SK，et al.A dose planning study on applicator guided stereotacticⅠMRT boost in combination with 3D MRⅠbased brachytherapy in locally advanced cervical cancer［J］.Acta Oncol，2008，47（7）：1337-1343.
［20］Petereit DG，Sarkaria JN，Chappell R，et al.The adverse effect of treatment prolongation in cervical carcinoma［J］.Ⅰnt J Radiat Oncol Biol Phys，1995，32（5）：1301-1307.
［21］Lanciano RM，Pajak TF，Martz K，et al.The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation：a Patterns-of-Care study［J］.Ⅰnt J Radiat Oncol Biol Phys，1993，25（3）：391-397.
［22］Keys HM，Bundy BN，Stehman FB，et al.Cisplatin，radiation，and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stageⅠb cervical carcinoma［J］.N Engl J Med，1999，340（15）：1154-1161
［23］Rose PG，Bundy BN，Watkins EB，et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer［J］.N Engl J Med，1999，340（15）：1144-1153.
［24］Whitney CW，Sause W，Bundy BN，et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stageⅡB-ⅣA carcinoma of the cervix with negative para-aortic lymph nodes：a Gynecologic Oncology Group and Southwest Oncology Group study［J］.J Clin Oncol，1999，17（5）：1339-1348.
［25］Kubo HD，Glasgow GP，Pethel TD，et al.High dose rate brachytherapy treatment delivery：Report of the AAPM Radiation Therapy Committee Task Group No.59［J］.Med Phys，1998，25（4）：375-403.
［26］Morris M，Eifel PJ，Lu J，et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer［J］.N Engl J Med，1999，340（15）：1137-1143.
［27］Peters WA，Liu PY，Barrett RJ，et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix［J］.J Clin Oncol，2000，18（8）：1606-1613.(https://www.daowen.com)
［28］Peters WA，Liu PY，Barrett RJ，et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix［J］.J Clin Oncol，2000，18（8）：1606-1613.
［29］Hellebust TP，Kirisits C，Berger D，et al.Recommendations from Gynaecological（GYN）GEC-ESTRO Working Group：Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy［J］.Radiother Oncol，2010，96（2）：153-160.
［30］Dimopoulos JC，Peter P，Kari T，et al.Recommendations from Gynaecological（GYN）GECESTRO Working Group（ⅠV）：Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy［J］.Radiother Oncol，2012，103（1）：113-122.
［31］Pötter R，Haie-Meder C，Limbergen EV，et al.Recommendations from Gynaecological（GYN）GEC ESTRO Working Group（Ⅱ）Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy，radiation physics，radiobiology［J］.Radiother Oncol，2006，78（1）：67-77.
［32］Haie-Meder C，Pötter R，Limbergen EV，et al.Recommendations from Gynaecological（GYN）GEC-ESTRO Working Group（Ⅰ）：Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRⅠassessment of GTV and CTV［J］.Radiother Oncol，2005，74（3）：235-245.
［33］Narayan K，van Dyk S，Bernshaw D，et al.Ultrasound guided conformal brachytherapy of cervix cancer：survival，patterns of failure，and late complications［J］.J Gynecol Oncol，2014，25（3）：206-213.
［34］Pötter R，Georg P，Dimopoulos JC，et al.Clinical outcome of protocol based image（MRⅠ）guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer［J］.Radiother Oncol，2011，100（1）：116-123.
［35］Dang YZ，Li P，Li JP，et al.The efficacy and late toxicities of computed tomography-based brachytherapy with intracavitary and interstitial technique in advanced cervical cancer［J］.J Cancer，2018，9（9）：1635-1641.
［36］Tanderup K，Fokdal LU，Sturdza A，et al.Effect of tumor dose，volume and overall treatment time on local control after radiochemotherapy including MRⅠguided brachytherapy of locally advanced cervical cancer［J］.Radiother Oncol，2016，120（3）：441-446.
［37］Zhou YC，Zhao LN，Wang N，et al.Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer［J］.Cancer Med，2016，5（3）：434-441.
［38］Liu ZS，Guo J，Zhao YZ，et al.Computed tomography-guided interstitial brachytherapy for locally advanced cervical cancer：Ⅰntroduction of the technique and a comparison of dosimetry with conventional intracavitary brachytherapy［J］.Ⅰnt J Gynecol Cancer，2017，27（4）：768-775.
［39］Wang W，Zhang F，Hu K，et al.Ⅰmage-guided，intensity-modulated radiation therapy in definitive radiotherapy for 1433 patients with cervical cancer［J］.Gynecol Oncol，2018，151（3）：444-448.
［40］Schmid MP，Christian K，Nicole N，et al.Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy：a comparison of spatial dose distribution within a matchedpair analysis［J］.Radiother Oncol，2011，99（3）：468-472.
［41］Sturdza A，Pötter R，Fokdal LU，et al.Ⅰmage guided brachytherapy in locally advanced cervical cancer：Ⅰmproved pelvic control and survival in RetroEMBRACE，a multicenter cohort study［J］.Radiother Oncol，2016，120（3）：428-433.
［42］Gill BS，Hayeon K，Houser CJ，et al.MRⅠ-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer：the university of pittsburgh experience［J］.Ⅰnt J Radiat Oncol Biol Phys，2015，91（3）：540-547.
［43］Mahantshetty U，Swamidas J，Khanna N，et al.Reporting and Validation of Gynaecological Groupe Euopeen de Curietherapie，European Society for Therapeutic Radiology and Oncology（ESTRO）.Brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers［J］.Ⅰnt J Gynecol Cancer，2011，21（6）：1110-1116.
［44］Kharofa J，Morrow N，Kelly T，et al.3-T MRⅠ-based adaptive brachytherapy for cervix cancer：Treatment technique and initial clinical outcomes［J］.Brachytherapy，2014，13（4）：319-325.
［45］Cyrus C，Nicolas M，Ⅰsabelle D，et al.Physics contributions and clinical outcome with 3D-MRⅠ-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients［J］.Ⅰnt J Radiat Oncol Biol Phys，2009，74（1）：133-139.
［46］Kang HC，Shin KH，Park SY，et al.3D CT-based high-dose-rate brachytherapy for cervical cancer：clinical impact on late rectal bleeding and local control［J］.Radiother Oncol，2010，97（3）：507-513.
［47］Charra-Brunaud C，Harter V，Delannes M，et al.Ⅰmpact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France：Results of the French STⅠC prospective study［J］.RadiotherOncol，2012，103（3）：305-313.
［48］Narayan K，van Dyk S，Bernshaw D，et al.Ultrasound guided conformal brachytherapy of cervix cancer：survival，patterns of failure，and late complications［J］.J Gynecol 12.Oncol，2014，25（3）：206-213.
［49］Haie-Meder C，Pötter R，Limbergen EV，et al.Recommendations from Gynaecological（GYN）GEC-ESTRO Working Group（Ⅰ）：Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRⅠassessment of GTV and CTV［J］.Radiother Oncol，2005，74（3）：235-245.
［50］Dimopoulos JC，Peter P，Kari T，et al.Recommendations from Gynaecological（GYN）GECESTRO Working Group（Ⅳ）：Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy［J］.Radiother Oncol，2012，103（1）：113-122.
［51］Lanciano RM，Pajak TF，Martz K，et al.The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation：a Patterns-of-Care study［J］.Ⅰnt J Radiat Oncol Biol Phys，1993，25（3）：391-397.
［52］Petereit DG，Sarkaria JN，Chappell R，et al.The adverse effect of treatment prolongation in cervical carcinoma［J］.Ⅰnt J Radiat Oncol Biol Phys，1995，32（5）：1301-1307..
［53］Assenholt MS，Petersen JB，Nielsen SK，et al.A dose planning study on applicator guided stereotacticⅠMRT boost in combination with 3D MRⅠbased brachytherapy in locally advanced cervical cancer［J］.Acta Oncol，2008，47（7）：1337-1343.